EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing

Stephen Rhee iD, Chunguang Xia, Aditya Chandra, Morgan Hamon iD, Geonhui Lee iD, Chen Yang iD, Zaixun Guo, Bingjie Sun

Bioengineering · 23.10.2024 · 11 (11) · 1055

DOI: 10.3390/bioengineering11111055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering, online erschienen am 23.10.2024. Verfasst von Stephen Rhee und 7 weiteren Autor:innen. Beteiligte Einrichtung: BMF Biotechnology, Inc., San Diego, CA 92121, USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BMF Biotechnology, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we present a novel 3D perfused skin-on-a-chip model fabricated using micro-precision 3D printing, which offers a streamlined and reproducible approach for incorporating perfusion. Perfused skin models are well-regarded for their advantages, such as improved nutrient supply, enhanced barrier function, and prolonged tissue viability. However, current models often require complex setups, such as self-assembled endothelial cells or sacrificial rods, which are prone to variability and time-consuming. Our model uses projection micro-stereolithography 3D printing to create precise microcapillary-like channels using a biocompatible resin, overcoming the drug-absorbing properties of PDMS. A customized chip holder allows for the simultaneous culture of six perfused chips, enabling high-throughput testing. The engineered skin-on-a-chip features distinct dermis and epidermis layers, confirmed via H&E staining and immunostaining. To evaluate drug screening capabilities, inflammation was induced using TNF-α and treated with dexamethasone, with cytokine levels compared to 2D cultures and human skin biopsies. Our 3D model exhibited drug response trends similar to human skin, while showing reduced cytotoxicity over time compared to biopsies. This perfused skin-on-a-chip provides a reliable, physiologically relevant alternative for drug and cosmetics screening, simplifying perfusion setup while preserving key benefits.

Schlagwörter

Stichwörter der Autor:innen

3D printingdrug screeningorgan-on-a-chipperfusionskinskin-on-a-chip

Autor:innen und Institutionen

  • BMF Biotechnology, Inc., San Diego, CA 92121, USA.
  • BMF Nano Material Technology Co., Ltd., Shenzhen 518100, China.

ORCID-Profile: Stephen Rhee, Morgan Hamon, Geonhui Lee, Chen Yang

Förderung

  • BMF Biotechnology, Inc.

Zitieren

APA

Rhee, S., Xia, C., Chandra, A., Hamon, M., Lee, G., Yang, C., Guo, Z., & Sun, B. (2024). Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing. Bioengineering, 11(11), 1055. https://doi.org/10.3390/bioengineering11111055

Vancouver

Rhee S, Xia C, Chandra A, Hamon M, Lee G, Yang C, et al. Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing. Bioengineering. 2024;11(11):1055. doi:10.3390/bioengineering11111055

BibTeX
@article{Rhee2024,
  author = {Rhee, Stephen and Xia, Chunguang and Chandra, Aditya and Hamon, Morgan and Lee, Geonhui and Yang, Chen and Guo, Zaixun and Sun, Bingjie},
  title = {Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing},
  journal = {Bioengineering},
  year = {2024},
  volume = {11},
  number = {11},
  pages = {1055},
  doi = {10.3390/bioengineering11111055}
}
Kostenlos starten →